Chronic kidney disease (CKD) can be challenging to diagnose, and our ability to determine the category of kidney disease using minimally or non-invasive samples is lacking. In this presentation Dr. Mary Nabity provides a review of the currently available tests for kidney disease diagnosis and monitoring in dogs, followed by a discussion of promising new biomarkers, including microRNAs. MicroRNAs are small non-coding RNAs that regulate gene expression and are thought to contribute to the progression of kidney disease. Furthermore, their stability in blood and urine supports their potential as biomarkers of disease. Those miRNAs that appear to be most promising as biomarkers or contributors to disease progression in dogs will be highlighted. Running time: 62 mins (includes 7 mins of audience Q and A) Fee: Free for Premium Membership subscribers or pay-per-view ($28)